1. Home >
  2. M&A >
  3. Going Private >
  4. United States >
  5. New Jersey >
  6. Gurnet Point Capital Acquires Innocoll

Going Private • Medical Products

Gurnet Point Capital Acquires Innocoll

On April 4, 2017, private equity firm Gurnet Point Capital acquired medical products company Innocoll for 209M USD

Acquisition Context
  • This is Gurnet Point Capital’s 1st transaction in the Medical Products sector.
  • This is Gurnet Point Capital’s 4th largest (disclosed) transaction.
  • This is Gurnet Point Capital’s 3rd transaction in the United States.
  • This is Gurnet Point Capital’s 1st transaction in New Jersey.

Explore All 36 Going Private Medical Products Deals - Search the Database Free


M&A Deal Summary
Date April 4, 2017
Target Innocoll
Sector Medical Products
Buyer(s) Gurnet Point Capital
Deal Type Going Private
Deal Value 209M USD
Advisor(s) Piper Sandler & Co. (Financial)

Target Company

Innocoll

Princeton, New Jersey, United States
Innocoll is a global commercial stage specialty pharmaceutical and medical device company with late stage development programs targeting areas of significant unmet medical need. Innocoll utilizes its proprietary collagen-based technology platform to develop biodegradable and fully bioresorbable products and product candidates which can be broken down by the body without the need for surgical removal or topical application. Innocoll’s proprietary processes and technologies also enable it to control the texture, consistency, drug elution dynamics, resorption time and other physical characteristics of the finished product. Innocoll was founded in 1985 and is based in Princeton, New Jersey.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Gurnet Point Capital

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2015
Size Small
Type Sector Focused
DESCRIPTION

Gurnet Point Capital is private investment group focused on the healthcare and life sciences sectors. The Firm looks to invest across all stages of product development through to commercialization and does so with an approach that is a hybrid of venture and private equity investing strategies. Gurnet Point Capital was formed in 2015 and is headquartered in Cambridge, Massachusetts.

Deal Context for Buyer #
Overall 3 of 7
Sector: Medical Products 1 of 1
Type: Going Private 1 of 4
State: New Jersey 1 of 1
Country: United States 3 of 7
Year: 2017 1 of 1
Size (of disclosed) 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-07 Crossover Health

San Clemente, California, United States

Crossover Health is a provider of employee health care that develops on-site and near-site health centers. Crossover Health designs and delivers a unique employee care experience for companies that understand the financial and cultural return of a healthy, motivated workforce. Crossover Health was founded in 2010 and is based in San Clemente, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-11 Corium

Boston, Massachusetts, United States

Corium is a commercial-stage biopharmaceutical company focused on the development, manufacture, and commercialization of specialty pharmaceutical products that leverage the company’s broad experience with advanced transdermal and transmucosal delivery systems. Corium was founded in 1995 and is based in Boston, Massachusetts.

Buy $504M

Explore Related M&A Activity

Medical Products M&A - Going Private M&A Deals - New Jersey M&A - United States M&A - 2017 M&A

Mergr

Solution for

Product

Company

Legal